The developers said such a signature could help triage people exposed to radiation through war, a terrorist attack, or an industrial accident.
Researchers in the US and Ukraine built a microRNA-based classifier to categorize infants as affected or unaffected.
Researchers from Northwestern University uncovered five circulating microRNAs that differentiate patients with very high- and low-risk prostate cancer.
A team of German researchers identified the four-microRNA signature and said it might inform treatment decisions.
The company sees microRNAs as the ideal blood-based biomarker for diagnosing and monitoring a number of diseases at the point of care and in the developing world.
The test could provide an early diagnosis of breast cancer by examining a handful of miRNA, microRNA, and proteomic biomarkers from urine samples.
The International Thyroid Congress and Annual Meeting of the American Thyroid Association announced studies validating diagnostics tests for several companies.
NIH researchers have uncovered a blood-based microRNA signature that may be able to tell which patients with precursor disease may progress to myeloma.
The grant is being provided under the NIH's Extracellular RNA Communication program, which was set up to study the role of molecules such as microRNAs.
The company has begun establishing partnerships with medical centers for a large prospective study of its test for identifying aggressive tumors.
The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.
The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.
Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.
In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.